Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Abstract Tau seed amplification assays (SAAs) directly measure the seeding activity of tau and would therefore be ideal biomarkers for clinical trials targeting seeding-competent tau in Alzheimer’s disease (AD). However, the precise relationship between tau seeding measured by SAA and the levels of...

詳細記述

書誌詳細

主要な著者:	Bryan Frey, David Holzinger, Keenan Taylor, Dagmar E. Ehrnhoefer, Andreas Striebinger, Sandra Biesinger, Laura Gasparini, Michael J. O’Neill, Florian Wegner, Stefan Barghorn, Günter U. Höglinger, Roland G. Heym
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-11-01
シリーズ:	Acta Neuropathologica Communications
主題:	Alzheimer’s disease Tau seeding Seed amplification assay (SAA) Real-time quaking induced conversion assay (RT-QuIC)
オンライン･アクセス:	https://doi.org/10.1186/s40478-023-01676-w
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!